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Abstract
Alcoholism and depression show high degrees of comorbidity. Clinical evidence also indicates
that depression that emerges during abstinence from chronic alcohol use has a greater negative
impact on relapse than pre-existing depression. Although no single neurobiological mechanism
can account for the behavioral pathologies associated with these devastating disorders, converging
evidence suggests that aspects of both alcoholism and depression are linked to reductions in
hippocampal neurogenesis. Here, we report results from a novel preclinical behavioral model
showing that abstinence from voluntary alcohol drinking leads to the emergence of depression-like
behavior and reductions in neurogenesis. C57BL/6J mice were allowed to self-administer ethanol
(10% v/v) vs H2O in the home cage for 28 days. Alcohol was then removed for 1 or 14 days, and
mice were tested in the forced swim test to measure depression-like behavior. After 14 days, but
not 1 day of abstinence from alcohol drinking, mice showed a significant increase in depression-
like behavior. The significant increase in depression-like behavior during abstinence was
associated with a reduction in proliferating cell nuclear antigen (PCNA) and doublecortin (DCX)
immunoreactivity in the dentate gyrus of the hippocampus indicating that both the number of
proliferating neural progenitor cells (NPC) and immature neurons were reduced, respectively. The
number of NPCs that were labeled with bromo-deoxyuridine (BrdU) at the beginning of alcohol
exposure was not altered indicating that survival of NPCs is not linked to abstinence-induced
depression. Chronic treatment (14 days) with the antidepressant desipramine during abstinence
prevented both the emergence of depression-like behavior and the reduction in hippocampal
neurogenesis indicating that abstinence-induced depression is associated with structural plasticity
in the hippocampus. Overall, the results of this study support the conclusion that profound
functional (ie behavioral) and structural changes occur during abstinence from alcohol use and
suggest that antidepressant treatment may alleviate some of these pathological neurobehavioral
adaptations.
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INTRODUCTION
Alcoholism and depression are two of the most costly and widespread neuropsychiatric
disorders worldwide. In the United States, the prevalence of a lifetime history of depression
in alcohol-dependent individuals has been reported to be about 42% (Miller et al, 1996;
Schuckit et al, 1997) but comorbidity rates from 5% to as high as 80% have been noted in
some studies (Pettinati, 2004). Alcohol abuse and/or dependence are also associated with a
two- to fourfold increase in depression rates (Grant, 1995; Kessler et al, 1997). Moreover,
rates of depression are significantly elevated among people who seek treatment for
alcoholism (Lynskey, 1998) and depressive symptoms are common in alcohol dependence
and abstinence (Garbutt et al, 1999). When alcoholism and depression co-occur, relapse to
alcohol use is more likely and remission from depression is less likely (Greenfield et al,
1998; Mueller et al, 1994).
Emerging evidence indicates that features of both alcoholism and depression may be
mediated by changes in adult hippocampal neurogenesis (Crews and Nixon, 2003; Duman et
al, 2000; Jacobs et al, 2000). For example, several antidepressant treatments increase
neurogenesis (Malberg et al, 2000; Santarelli et al, 2003; Warner-Schmidt and Duman,
2006), although stress, which is widely thought to precipitate depression, reduces
neurogenesis (Cameron and Gould, 1994; Gregus et al, 2005; Malberg and Duman, 2003;
Tanapat et al, 2001). In addition to stress, alcohol has been shown to reduce neurogenesis.
Studies have shown that high levels of alcohol exposure can reduce survival and
proliferation of neural progenitor cells (NPC) (He et al, 2005; Herrera et al, 2003; Nixon
and Crews, 2002). Withdrawal from alcohol exposure is associated with time-dependent
increases and decreases in proliferation of NPCs (Nixon and Crews, 2002). These data led
us to hypothesize that decreased hippocampal neurogenesis may be a neurobiological
mechanism that contributes to the co-occurrence of alcoholism and depression.
Factors that reduce neurogenesis, such as stress and dysregulation of monoamines (Jacobs et
al, 2000), have been shown to increase depression-like behavior (Hwang et al, 1999;
Johnson et al, 2006; Plaznik et al, 1988; Prince and Anisman, 1984) as measured by the
forced swim test (FST) in rodents (Porsolt et al, 1977). Major classes of antidepressants
including tricyclic antidepressants, selective serotonin reuptake inhibitors, and monoamine
oxidase inhibitors show efficacy in the FST (Cryan et al, 2005; Dalvi and Lucki, 1999;
Lucki et al, 2001) and increase hippocampal neurogenesis (Malberg et al, 2000). Moreover,
antidepressant efficacy in rodent behavioral models may require hippocampal neurogenesis
(Santarelli et al, 2003). It is not known if antidepressants reverse alcohol-induced changes in
neurogenesis or depression-like behavior.
Important clinical evidence indicates that depression that emerges during abstinence
following alcohol drinking has a greater negative impact on relapse rates than pre-existing
depression (Hasin et al, 2002), yet preclinical studies on this topic are lacking. In this study,
we report the development and validation of a novel model of alcohol abstinence-induced
depression-like behavior in mice as measured by the FST (Porsolt et al, 1977). Using this
model, we demonstrate that abstinence-induced changes in depression-like behavior are
associated with reduced hippocampal neurogenesis, and that this deficit is reversed in
association with the positive behavioral effects of antidepressant treatment.
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Adult male C57BL/6J mice (The Jackson Laboratory, Bar Harbor, ME) were singly housed
in standard Plexiglas cages with Purina Rodent Chow and fluid always available. Mice were
9 weeks old at the start of all experiments, and weighed between 22–26 g at the beginning of
the experiments. At the end point of experiments, mice weighed between 25–31 g. The
vivarium was maintained at 27°C on a reverse 12 : 12 light/dark cycle (lights on at 2200 h).
Animals were under continuous care and monitoring by veterinary staff from the Division of
Laboratory Animal Medicine at UNC-Chapel Hill, and all procedures were also carried out
in accordance with institutional guidelines.
Experimental Procedures
In the first set of experiments, mice were weighed and handled daily for 7 days prior to
experiments to facilitate adaptation to the laboratory (Figure 1a). All mice were
administered BrdU (see the Drugs section) once per day for 3 days. Animals were then
randomly assigned to experimental groups. Experimental groups were as follows: alcohol-
drinking mice were allowed to voluntarily consume alcohol or water for 28 days using a
two-bottle drinking procedure and were behaviorally tested after 1 (n = 12) or 14 (n = 12)
days of abstinence; water-only controls (n = 12) had access to two bottles of water for 28
days and then were behaviorally tested one day later. Mice were returned to the vivarium
after behavioral testing and brains were removed 24 h later (Figure 1a).
In the second set of experiments, mice were allowed 7 days to adapt to handling and the
laboratory environment (Figure 1b). Mice were randomly assigned to the following
treatment conditions: two groups of alcohol-drinking mice voluntarily consumed alcohol or
water for 28 days using a two-bottle drinking procedure (see below); one group of water-
only controls had access to two bottles of water for 28 days. Alcohol-drinking mice then
received injections of either vehicle (n = 12) or desipramine (n = 12, see Drugs below)
during a 14-day abstinence period. Water-only control mice received daily injections of
either vehicle (n = 12) or desipramine (n = 12) in parallel to the alcohol-abstinent mice.
Water-only mice that received vehicle injections served as a control for alcohol exposure
and injection stress. In addition, this group allowed us to rule out potential effects of aging
on neurogenesis. The first injection was given the same day that alcohol bottles were
removed from the cages, so that the 14th injection occurred 13 days after removal of
alcohol. Behavior of all mice was evaluated in the forced swim test 1 day after the final
desipramine injection (Figure 1b). Desipramine was not administered on behavioral test
days, to examine the effects of chronic, but not acute, antidepressant treatment. Animals
were killed 24 h after behavioral testing (Figure 1b).
An additional experimental group was included in immunohistochemical studies in which
animals were killed at the end of their 28th day of alcohol drinking (0 days of abstinence).
This group was not included in behavioral studies to avoid potential confounding effects of
acute alcohol.
Two-Bottle Drinking Procedure
During the 1-week period of acclimation and handling, water was the only fluid available.
All fluids were presented in the home cage through 50 ml plastic centrifuge bottles with
stainless steel sipper tubes. Alcohol-drinking mice were then given access to one bottle of
water and one bottle of alcohol (10%v/v) as previously described (Hodge et al, 1999).
Animals were weighed and the fluid levels in the bottles were monitored to the nearest 0.5
ml at 24-h intervals to determine daily fluid intake (ml and g/kg). The position (left–right) of
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the alcohol and water bottle was changed each day to control for side preferences. Mice
were given access to alcohol for 28 days. Control animals had access to two bottles of water
for the same duration (28 days). On day 23 of alcohol drinking, tail blood was collected and
analyzed for blood alcohol level. On the final day of drinking, the alcohol solution-
containing bottle was removed from the cages of alcohol drinkers, and one water bottle was
removed from the cages of controls; thus, during abstinence only one bottle was on each
cage.
Blood Alcohol Determination
Blood alcohol level was measured from tail vein blood samples taken between 2 and 3 h into
the dark cycle as an index of alcohol intake. Individual blood samples (approximately 20 μl)
were centrifuged and 5 μl of plasma from each sample was used to determine alcohol
concentration using an AM1 Alcohol Analyzer (Analox Instruments, Lunenburg, MA).
Behavioral Testing
Open-field locomotor activity and anxiety-like behavior—Mice were first tested for
spontaneous locomotor activity and anxiety-like behavior (thigmotaxy) in brightly lit (500
lux) chambers (28 cm × 28 cm) during 15 min sessions as described (Hodge et al, 2002). For
assessment of activity in the center of the field, the chamber floor was divided post hoc into
a center zone (14 × 14 cm; center equidistant from all four walls of the chamber) and a
periphery zone (the remaining area of the floor). Total horizontal distance (cm) traveled
(locomotor activity) and time spent in the center zone (anxiety-like behavior) were
calculated from the locomotor activity data. After each test session, the equipment was
cleaned with acetic acid (2%) to limit animal odors. Locomotor tests were conducted
between 1100 and 1200 h (1–2 h into the dark cycle).
Depression-like behavior—Three hours after locomotor activity testing, depression-like
behavior was assessed using the FST (Porsolt et al, 1977). Mice were placed in a 2000 ml
beaker containing 1300 ml of water maintained at 23–25°C for 6 min. Behavior was
videotaped for later analysis by two trained observers who were blind to the treatment
conditions. The duration of immobility during the last 4 min of the FST was measured
during a single session as an index of depression-like behavior. Mice were considered
immobile if they were completely still except for small movements of the paw made only to
keep the mouse afloat, and not producing any noticeable propulsion of the mouse.
Drugs
Bromo-deoxyuridine (BrdU) (Sigma-Aldrich, St Louis, MO) (300 mg/kg, 15 ml/kg,
dissolved in saline, i.p.), used here as a marker of surviving neural progenitor cells, was
administered once a day for 3 days before the onset of alcohol drinking. Where indicated,
mice were injected with desipramine-HCl (Sigma-Aldrich, St Louis, MO) (15 mg/kg, 10 ml/
kg, i.p.) or vehicle (0.9% saline, 10 ml/kg, i.p.) once per day for 14 days during abstinence.
The antidepressant desipramine was used in this study because it has been shown to be
highly effective (more so than fluoxetine) in the FST in C57BL/6J mice (Lucki et al, 2001).
This particular dose of desipramine was selected based on its efficacy in the FST and its
ability to produce hippocampal neuroadaptive changes (Lucki et al, 2001; Thome et al,
2000).
Tissue Fixation and Sectioning
Animals were deeply anesthetized with pentobarbital (60 mg/kg, 10 ml/kg, i.p.) and
perfused transcardially with 0.1 M phosphate-buffered saline (PBS) followed by 4%
paraformaldehyde. The brains were removed from the skull and placed in the same fixative
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solution for at least 24 h before being washed with PBS and sliced on a Leica VT 1000S
vibrating microtome into 40 μm sections. The free-floating sections were stored in
cryoprotectant at –20C until immunohistochemistry was performed.
Immunohistochemistry
Tissue was washed in PBS, and then treated with 0.6% hydrogen peroxide to block
endogenous peroxidase activity. Tissue was incubated for 1 h in a blocking solution (3%
horse serum, 0.1% Triton-X, 0.1 M PBS) before incubation in the primary antibody.
Sections were incubated in the antiproliferating cell nuclear antigen antibody (EMD
Biosciences Inc., San Diego, CA; dilution 1 : 400) overnight at 4°C or in the anti-
doublecortin antibody (Santa Cruz Biotechnology Inc., Santa Cruz, CA; dilution: 1 : 1000)
for 48 h at 4°C. The following day, tissue sections were rinsed in PBS before incubation in
the appropriate secondary antibody (Vector Laboratories, CA) for 1 h. Tissue was then
processed with avidin–biotin complex (Vector ABC kit, Vector Laboratories, CA) and
immunoreactivity was visualized with DAB (Polysciences Inc., PA). Tissue sections were
then rinsed in PBS and, in the case of proliferating cell nuclear antigen (PCNA)
immunohistochemistry, counter-stained with toluidine blue before the sections were
mounted onto slides.
For BrdU immunohistochemistry, tissue was prepared according to the method of Nixon and
Crews (2002). Tissue was washed in PBS, and then treated with 0.6% hydrogen peroxide to
block endogenous peroxidase activity. Next, tissue was incubated in 50% formamide/2 ×
SSC for 2 h at 65°C, then in 2N HCl for 1 h at 37°C. After neutralizing in 0.1 M boric acid,
tissue was rinsed in PBS, then incubated overnight at 4°C in primary antibody (anti-BrdU:
Accurate Chemical and Scientific Corp., NY; dilution 1 : 400). The following day was
performed as described above for PCNA immunohistochemistry. Antibody dilutions were
chosen based on dilution curves, and antibody specificity was verified secondary only to
controls in all immunohistochemical assays.
Analysis of immunohistochemistry
For BrdU and PCNA immunohistochemistry, immunopositive cells in the dentate gyrus
were counted manually with an oil immersion lens (Plan Apo × 60 oil; numerical aperture,
2.0; Olympus Optical, Melville, NY). Profile counting methodology was used as it has
previously been shown that profile counting and stereological estimations show identical
results in percentage change (Crews et al, 2004). Moreover, stereology may not be
appropriate for quantifying BrdU + cells, because they are not homogeneously distributed
throughout the dentate (Popken and Farel, 1997). Cell counts are expressed as the number of
immunopositive cells per dentate gyrus section. For doublecortin immunohistochemistry,
image analysis software (Bioquant Nova Advanced Image Analysis; R&M Biometric,
Nashville, TN) was used to measure optical densitometry of the staining. Densitometry
measurements are divided by the area of the section and expressed as pixels/mm2. Every
sixth section within stereotaxic range from Bregma –1.46 mm to Bregma –2.54 mm
(Paxinos and Franklin, 2001) was analyzed to generate an average cell count or pixel density
for each subject. Experimenter performing immunohistochemical analyses was blind to the
treatment condition of the subjects. Desitometry analyses were repeated during a subsequent
Bioquant session to ensure that results replicated.
Immunofluorescence
Triple-label confocal microscopy was performed according to Nixon and Crews (2004). The
colocalization of BrdU with neuronal-specific nuclear protein (NeuN) or glial fibrillary
acidic protein (GFAP) proteins was used to characterize the fate of surviving NPCs. Tissue
was washed in PBS, then incubated in a blocking buffer. Tissue was then incubated in a
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solution containing primary antibodies (rat anti-BrdU, Accurate, Westbury, NY; dilution 1 :
400; mouse anti-NeuN, Chemicon, Temecula, CA; dilution 1 : 500; rabbit anti-GFAP, Dako,
Glostrup, Denmark; dilution 1 : 2000). The following day, tissue was rinsed in PBS, and
then incubated in the dark with fluorescent-coupled secondary antibodies appropriate for
each primary antibody. Tissue was then rinsed in PBS and mounted onto slides, taking care
to protect the sections from the light. Slides were cover-slipped using ProLong Anti-Fade
reagent (Molecular Probes, OR).
Visualization and Analysis of Immunofluorescence
Triple-label immunofluorescence was visualized with a Zeiss (Oberkochen, Germany)
Axiovert LSM510 confocal microscope on multitrack setting with a water immersion lens
(C-Apochromat × 40/1.2 W corr). Colocalization was confirmed by confocal microscopy
optimized for the analysis of tissue sections. For each subject, 50 BrdU-labeled cells were
analyzed for colocalization with GFAP or NeuN. Percentages of BrdU-labeled cells that
colabeled with each cell type were determined. The 50 cells were selected from several
fields in a minimum of five tissue sections. Z-plane section images (512 × 512 pixels) were
collected at <1 μm thickness and then analyzed using LSM Image Examiner software
(Zeiss). The criteria for colabeling included appropriate morphology and more than two Z-
plane images of co-positive staining.
Statistical analyses
In the first set of experiments, between subjects one-way analysis of variance (ANOVA)
were used to analyze changes in behavior and immunohistochemistry. Post hoc Dunnett's
tests were conducted to determine if treated groups were different from control. In the
second set of experiments, between subjects two-way ANOVA were used to analyze
changes in behavior and immunohistochemistry. Post hoc Tukey tests were used to
determine between-group differences. Statistical significance was always defined as p<0.05.
All statistical procedures were conducted with SigmaStat v3 software (Systat Software Inc.,
San Jose, CA).
RESULTS
Abstinence following Alcohol Drinking is Associated with an Increase in Depression-Like
Behavior
To determine if abstinence following alcohol drinking is associated with changes in
depression-like behavior, FST performance of water-only control mice was compared to
mice that consumed alcohol for 28 days followed by 1 or 14 days of abstinence.
Alcohol exposed mice voluntarily consumed average of 17.8 ± 1.0 g/kg/day of alcohol (10%
v/v) in the home cage for 28 days, which resulted in average peak blood alcohol levels of
112.8 ± 7.4 mg/dl. Total fluid intake did not differ between water- and alcohol-exposed mice
(data not shown). One-way ANOVA on FST data showed a significant main effect of
exposure condition (F(2, 33) = 3.53, p<0.05) that was due to a 36% increase in immobility
following 14 days of abstinence as compared with water-only controls (p<0.05, Dunnett's
test). No significant increase in immobility was evident 1 day after cessation of alcohol
drinking (p>0.05, Dunnett's test; Figure 2a). These data show for the first time that alcohol
drinking, followed by abstinence, leads to an emergent increase in depression-like behavior.
Abstinence following Alcohol Drinking is Associated with a Transient Increase in Anxiety-
Like Behavior
Anxiety-like behavior was also evaluated by measuring the amount of time spent in the
center of an open field immediately prior to the FST. A one-way ANOVA comparing water
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mice with mice that drank alcohol for 28 days followed by 1 or 14 days of abstinence
demonstrated a significant difference in time spent in the center of an open field (F(2, 33) =
13.33, p<0.001) (Table 1). A significant decrease in the amount of time spent in the center
of an open field was evident in mice after 1 day of abstinence (p<0.05, Dunnett's test) but
not 14 days of abstinence (p>0.05, Dunnett's test). These data indicate a temporary increase
in anxiety-like behavior after 1 day of abstinence that disappears by 15 days of abstinence.
Overall locomotor activity was analyzed 1 or 14 days after the removal of alcohol access. A
one-way ANOVA showed an overall difference in locomotor activity (F(2, 33) = 4.26, p =
0.02) (Table 1); however, post hoc comparisons revealed that neither alcohol treatment
differed from control (p<0.05, Dunnett's test). These data show that differences observed in
depression-like and anxiety-like behavior were not attributable to alterations in motor
ability.
Survival and Differentiation of Neural Progenitor Cells
Survival of hippocampal NPCs is reduced by exposure to forced alcohol liquid diet in rats
that causes high blood alcohol levels (Herrera et al, 2003). However, the effects of
abstinence following chronic voluntary drinking on the survival of NPCs are not known.
BrdU was injected before the onset of drinking to assess the number of dividing cells that
survived until the brains were removed. There was no significant difference (F(2, 29) = 1.67,
p = 0.207) in the number of BrdU-labeled cells per dentate gyrus that remained after 1 or 14
days of abstinence following chronic voluntary drinking compared with water-only controls
(Figure 3a). Representative images of BrdU immunohistochemistry in the dentate gyrus are
shown (Figure 3b). These results indicate that neither short-term nor protracted abstinence
affects the survival of NPCs in this model of alcohol consumption. Although no change in
the number of surviving BrdU-labeled cells was evident, the number of surviving NPCs that
became neurons or glia could have been affected. Triple-label immunofluorescence,
however, revealed that the remaining BrdU-labeled cells underwent neuronal and glial
differentiation at the expected rates (Nixon and Crews, 2004). Of the BrdU-labeled cells
analyzed from alcohol drinkers (n = 50 cells/animal) and water-only controls (n = 50 cells/
animal), 89 and 92% colocalized with NeuN in the dentate gyrus, respectively.
Representative immunofluorescence in the dentate gyrus is shown (Figure 3c and d). These
data indicate chronic voluntary drinking does not affect the percentage of neuronal
differentiation of surviving NPCs.
Proliferation of Neural Progenitor Cells
Although survival of NPCs was unchanged by voluntary alcohol drinking and abstinence, it
is possible that other stages of neurogenesis, such as proliferation, were affected. Previous
studies have demonstrated biphasic alterations in NPC proliferation associated with alcohol
exposure and withdrawal (Aberg et al, 2005; Crews et al, 2004; He et al, 2005; Nixon and
Crews, 2002). To determine if abstinence from chronic drinking (and depression-like
behavior) is associated with changes in NPC proliferation, serial sections of hippocampus
were immunolabeled with PCNA, which is a cell cycle-specific nuclear protein belonging to
the replication complex that permits DNA synthesis needed for G1 to S transition(Krude,
1999; Yew et al, 2001) and correlates with the proliferative state of cells (Celis et al, 1987).
One-way ANOVA comparing PCNA cell counts from alcohol drinking mice to water-only
control mice revealed a main effect (F(3, 36) = 6.5, p = 0.001). Follow up comparisons
showed that abstinence following alcohol drinking for 14 days produced a significant
decrease in NPC proliferation (p<0.05, Dunnett's test) as indexed by the number of PCNA-
labeled cells, while 0 and 1 day of abstinence did not produce a change in PCNA
immunoreactivity (Figure 4a). Representative photomicrographs illustrating PCNA
immunoreactivity in the dentate gyrus are shown in Figure 4c. These results indicate that 14
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days of abstinence following voluntary drinking leads to a decrease in the proliferation of
NPCs in the dentate gyrus.
Number of Immature Neurons
Another approach to assessing neurogenesis is to examine the number of immature neurons
in the dentate gyrus. Doublecortin immunohistochemistry can be used to determine the
density of cells in the hippocampus that have proliferated, survived, differentiated into
neurons, and begun to develop neurites (Couillard-Despres et al, 2005; Rao and Shetty,
2004). The main effect was revealed by a one-way ANOVA comparing alcohol-drinking
animals with water-only controls (F(3, 40) = 8.2, p = 0.001). Similar to results from PCNA
immunohistochemistry, the density of doublecortin immunoreactivity was significantly
decreased following 14 days (p<0.01, Dunnett's test), but not 0 or 1 day of abstinence
following alcohol drinking relative to control (Figure 4b). Representative photomicrographs
illustrating DCX immunoreactivity in the dentate gyrus are shown in Figure 4d. These data
suggest that the number of new neurons in the dentate gyrus is reduced following 14 days of
abstinence following voluntary drinking.
Antidepressant Treatment during Abstinence
To determine if the emergence of depression-like behavior during abstinence can be
prevented by administration of antidepressant medication, mice were given a single injection
of desipramine each day for 14 days beginning the day alcohol was removed from the home
cage. The day after the last desipramine injection, mice were tested in the FST. Desipramine
was also used here to validate that the increase in immobility in the FST was a depression-
related behavior. Results indicated that chronic desipramine treatment prevented the
emergence of depression-like behavior in mice that were treated with the antidepressant
during 2 weeks of abstinence following chronic drinking. Antidepressant treatment had no
effect on the behavior of mice with no history of drinking. A two-way ANOVA found a
significant interaction between alcohol drinking history and antidepressant treatment (F(1,
41) = 9.74, p = 0.003); there was no main effect of alcohol or desipramine alone. Post hoc
multiple comparison procedures showed that immobility was increased in ethanol drinking
mice relative to water controls under the vehicle condition (p = 0.007, Tukey test),
indicating that abstinence following chronic drinking was associated with increased
depression-like behavior. Within ethanol-drinking mice, desipramine treatment significantly
decreased immobility in the FST (p = 0.008, Tukey test), demonstrating that desipramine
prevents increases in depression-like behavior following abstinence from chronic drinking
(Figure 5a). Moreover, alcohol-exposed mice that received desipramine treatment did not
differ from water controls, indicating that the depression-like behavior that emerged during
abstinence was fully blocked by the antidepressant desipramine.
Although studies have indicated that increasing neurogenesis may be a mechanism by which
antidepressants produce their behavioral effects, we tested the ability of desipramine to
block the decrease in neurogenesis associated with the emergence of depression-like
behavior following 2 weeks of abstinence from chronic drinking. Immunohistochemical
analyses of PCNA and DCX expression were performed to measure proliferation of NPCs
and the number of immature neurons, respectively, 14 days after cessation of chronic
drinking. Two-way ANOVA revealed no main effect of alcohol drinking or anti-depressant
treatment alone on the number of PCNA-labeled cells. Importantly, however, there was a
significant interaction between alcohol drinking history and desipramine treatment (F(42, 1)
= 4.71, p = 0.036). Post hoc multiple comparisons (Tukey test) showed that the interaction
was because of a significant reduction in the number of PCNA-labeled cells in alcohol
drinking mice as compared with water controls in the vehicle condition (p = 0.012, Figure
5b). The number of PCNA-positive cells following desipramine treatment was not different
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from water controls (Figure 5b). These data indicate that abstinence following chronic
drinking decreases the number of proliferating cells in the dentate gyrus, and that this
decrease is blocked by administration of desipramine during the abstinence period.
Similarly, a two-way ANOVA found only a significant interaction between alcohol-drinking
history and antidepressant treatment on DCX density (F(41, 1) = 10.3, p = 0.003). As shown
in Figure 5c, DCX density was reduced in alcohol-exposed mice within the vehicle
condition as compared with water controls (p = 0.004, Tukey test). Also, desipramine
blocked the reduction in DCX density in alcohol-exposed mice (p = 0.005, Tukey test).
Representative photomicrographs illustrating PCNA and DCX immunoreactivity in the
dentate gyrus are shown in Figure 5d and e, respectively. Taken together, these data suggest
that abstinence following chronic drinking leads to decreased neurogenesis in the dentate
gyrus, and that desipramine treatment during abstinence prevents this decrease.
DISCUSSION
Clinical studies have noted high degrees of comorbidity between alcoholism and depression
(Pettinati, 2004) and shown that depression that emerges during abstinence increases the
likelihood of relapse (Hasin et al, 2002). Although little is known about the factors that
promote this comorbidity, converging evidence implicates reductions in hippocampal
neurogenesis as a mechanism that may underlie pathologies associated with both alcoholism
and depression (Nixon, 2006; Warner-Schmidt and Duman, 2006). In this study, we show
that depression-like behavior is increased during abstinence following voluntary alcohol
drinking in mice. This behavioral pathology is associated with a reduction in hippocampal
neurogenesis and treatment with the antidepressant desipramine restores the behavior and
measurements of neurogenesis to normal levels. From these results, we propose that reduced
hippocampal neurogenesis reflects a neuroadaptive process that underlies depression-like
behavior that emerges during abstinence following alcohol drinking.
Though alcoholism is commonly associated with human depression, a functional
relationship between alcohol consumption and depression-like behavior in a preclinical
model has not been demonstrated previously. Using a novel mouse behavioral model, this
study establishes an important link between abstinence following alcohol drinking and
depression. In mice that voluntarily consumed alcohol for 28 days, increased depression-like
behavior as measured by the FST was evident 14 days after alcohol was removed from the
home cage. Although FST performance showed a trend after 1 day of abstinence, this
increase in depression-like behavior was not significantly different from water controls. This
suggests that the depression-like behavior was dissociated from any immediate effects of
alcohol exposure or withdrawal. Further, the absence of reductions in overall locomotor
activity suggests that the voluntary alcohol drinking procedure did not produce dependence
(Pohorecky, 1976). Overall, these results suggest that neuroadaptive changes that occur
during protracted abstinence following alcohol drinking lead to the emergence of
depression-like behavior, even in moderate drinkers.
In addition to identifying the emergence of depression-like behavior during protracted
abstinence, the results of this study complement numerous investigations that have
established a link between alcohol withdrawal and anxiety. For example, withdrawal from
alcohol liquid diet, chronic injections, vapor exposure, or consumption from a single
drinking bottle increase anxiety-like behavior in mice that persists for up to 48 h after
alcohol exposure (Costall et al, 1988; Joshi et al, 2005; Kliethermes et al, 2004; Prediger et
al, 2006; Sparta et al, 2007). Similar results have been obtained in rat models showing
increased anxiety-like behavior during acute and early withdrawal from an alcohol liquid
diet (Baldwin et al, 1991; Moy et al, 1997; Pandey et al, 1999; Rassnick et al, 1993). In the
present study, we observed increased anxiety-like behavior in non-dependent mice 1 day
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after voluntary alcohol drinking as measured by an open-field thigmotaxy assay. Alcohol-
exposed mice did not differ from water controls when anxiety-like behavior was measured
after 2 weeks of abstinence. Accordingly, other data show that withdrawal from alcohol
vapor increases anxiety-like behavior in rats during acute (8 h) withdrawal but the effect
dissipates by 2 weeks (Zhao et al, 2007). However, studies have reported increased anxiety-
like behavior at 4 (Rasmussen et al, 2001) and 12 weeks (Zhao et al, 2007) after withdrawal
from alcohol liquid diet or vapor exposure, respectively. Together, these and other data
(reviewed by (Kliethermes, 2005) suggest that anxiety is a prominent feature of abstinence
that may dissipate or cycle over time. Importantly, we found no evidence of increased
anxiety-like behavior after 2 weeks of abstinence when depression-like behavior emerged,
which suggests a time-dependent dissociation of these behavioral pathologies during
abstinence.
A key finding of this preclinical study is that chronic treatment with the antidepressant
desipramine during abstinence completely blocked the emergence of abstinence-induced
depression as measured by the FST in mice. Although the FST is most widely used as a
behavioral screen for antidepressant efficacy, previous studies have also demonstrated that
factors associated with human depression including chronic stress, inescapable stress,
dysregulated monoamine function, and elevated glucocorticoids produce immobility in the
FST (Hwang et al, 1999; Johnson et al, 2006; Plaznik et al, 1988; Prince and Anisman,
1984). The efficacy of desipramine validates the FST as a measure of depression in the
present study. Importantly, the dose of desipramine used had no effect on behavior in the
FST in water-only control mice. Furthermore, the prevention of depression-like behavior
with desipramine, a tricyclic antidepressant, suggests that abstinence following chronic
drinking may lead to dysregulation of noradrenergic and other monoaminergic systems, and
that desipramine may prevent this dysregulation. Additional mechanistic studies are required
to test this hypothesis.
While the effectiveness of antidepressants in treating depression is well validated, potential
efficacy of these compounds in the treatment of alcoholism needs further study. There are
only a limited number of well-controlled clinical studies on the efficacy of antidepressant
use for alcoholics (Ostacher, 2007). Clinical studies have demonstrated that antidepressants
are effective in reversing depression comorbid with alcoholism, and have shown modest
success in preventing relapse (Le Fauve et al, 2004). As mentioned above, depression that
occurs during abstinence has been linked to an increased risk of relapse (Hasin et al, 2002).
When taken together with the present results, these findings suggest that antidepressant
treatment that begins concurrently with cessation of drinking may be helpful in preventing
the emergence of abstinence-related depression in the clinic. In addition, the beneficial
effect of antidepressant treatment during abstinence provides further support for the
conclusion that depression-like behavior may be functionally linked to abstinence-induced
neuroadaptive changes.
The concept of adult neurogenesis has provided a new framework (eg the idea of structural
plasticity) for understanding neuroadaptive changes in the adult brain, which extends
prevailing theories that regard changes in synaptic efficacy (Hebb, 1949) as a solitary
mechanism of neuroplasticity (Gage, 2002). Accumulating evidence now indicates that
NPCs exist in a variety of mammalian brain regions where they give rise to new neurons,
astrocytes, and oligodendrocytes throughout life (for a recent review see (Ming and Song,
2005)). Neurogenesis in the adult brain is a dynamic process that can be influenced by
internal and external events that also influence behavior (for reviews see (Carlezon et al,
2005; Crews and Nixon, 2003; Duman et al, 1999; Gage, 2002; Henn and Vollmayr, 2004;
Kempermann, 2002; Ming and Song, 2005). In general, evidence suggests that new neurons
in the adult brain contribute to synaptic plasticity (Snyder et al, 2001), as well as the general
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ability of the organism to adapt to changing circumstances (Kempermann, 2002). Thus,
neurogenesis is a structural event that may have functional consequences. Indeed, emerging
evidence suggests that hippocampal neurogenesis may be functionally linked to stress and
mood disorders (Dranovsky and Hen, 2006; Malberg and Blendy, 2005; Mirescu and Gould,
2006; Warner-Schmidt and Duman, 2006) cf. (Henn and Vollmayr, 2004).
Generation of functional new neurons by neurogenesis requires proliferation, differentiation,
and survival of NPCs. In this study, we sought to determine if abstinence following
voluntary alcohol drinking (and depression-like behavior) is associated with changes in adult
hippocampal neurogenesis. To address this goal, serial sections of hippocampus were
immunolabeled for PCNA, which labels proliferating cells. Results showed that 14 days of
abstinence following alcohol drinking was associated with a 40% reduction in the number of
PCNA-positive cells (cells in the process of proliferating) in the dentate gyrus as compared
with water-only control mice. Abstinence from alcohol drinking was also associated with a
40% reduction in immunoreactivity for DCX, which is a protein expressed by new cells that
are in the process of differentiating into mature neurons. However, no reductions in PCNA
or DCX immunoreactivity were observed at 0 or 2 days after alcohol indicating that the
reduction in proliferating and differentiating NPCs emerged during protracted abstinence.
These results indicate that abstinence-induced depression-like behavior in mice is associated
with a concomitant reduction in hippocampal neurogenesis.
In contrast to the effect of protracted abstinence, we found no effect of 28 days of voluntary
alcohol drinking, or short-term abstinence (2 days), on adult hippocampal neurogenesis
(Figure 4b). Several studies have demonstrated that exposure to high doses of alcohol has a
detrimental effect on adult hippocampal neurogenesis. For example, exposure to alcohol
through binge injection or forced liquid diet models in rats produces significant decreases in
proliferating NPCs and differentiating neurons (He et al, 2005; Nixon and Crews, 2002). In
mouse models of voluntary alcohol drinking, high dose intake (> 25 g/kg/day) is also
associated with a profound decrease (Crews et al, 2004), whereas lower dose intake (6 g/kg/
day) is associated with an increase in NPC proliferation (Aberg et al, 2005). In the present
study, we found that 17–18 g/kg/day of voluntary alcohol intake produced no change in
proliferating or differentiating NPCs in the dentate gyrus in mice. Together these studies
suggest that alcohol produces dose-dependent effects on hippocampal neurogenesis.
Emerging studies have also shown that exposure to high doses of alcohol through binge
injection or liquid diet reduces NPC survival in rats (He et al, 2005; Herrera et al, 2003;
Nixon and Crews, 2002). To determine if voluntary alcohol drinking and/or abstinence is
associated with changes in NPC survival, mice were injected with BrdU just before the onset
of 28 days of alcohol drinking, and the number of surviving cells was measured following 2
or 14 days of abstinence. Results showed that the number of BrdU-positive cells in the
dentate gyrus of alcohol-exposed mice was unchanged following short-term or protracted
abstinence as compared to water-only controls. Although the overall number of surviving
NPCs was unchanged, it is possible that there was a change in the number of surviving cells
that became neurons rather than glia. However, the data from triple-label
immunofluorescence experiments, found no difference in the percentage of BrdU-positive
cells that were colabeled with either GFAP or NeuN in the dentate gyrus of alcohol-exposed
mice as compared with water-only controls. These data indicate that the abstinence-induced
depression-like behavior in the present study was not associated with changes in the survival
rate or phenotype of cells born before the onset of drinking. Thus, alcohol-induced changes
in the survival of NPCs may require higher doses of alcohol than those that are achieved by
voluntary drinking in mice.
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Because it is known that factors that precipitate depression, such as stress and increased
glucocorticoids, decrease hippocampal neurogenesis (Mirescu and Gould, 2006) and that
antidepressants increase hippocampal neurogenesis (Malberg and Blendy, 2005; Malberg et
al, 2000; Santarelli et al, 2003), we sought to determine if antidepressant treatment is
effective in preventing abstinence-induced impairments in hippocampal neurogenesis that
occur in parallel with depression-like behavior. Chronic treatment with the antidepressant
desipramine during 14 days of abstinence following alcohol drinking prevented the decrease
in the number of immature neurons, as well as the number of proliferating cells in the
dentate gyrus. Although the decrease in proliferating cells was smaller in the second
experiment relative to the first, this effect was because of lower raw data control values in
the second experiment. We hypothesize that decreased proliferation in the control animals in
the second experiment could be because of the effects of daily injections. It is worth noting
that 14 days of desipramine administration had no effect on hippocampal neurogenesis in
water-drinking mice as measured by PCNA and DCX immunohistochemistry. These data
suggest that chronic desipramine treatment did not simply cause an overall increase in
neurogenesis, but rather prevented abstinence-induced decreases in hippocampal
neurogenesis.
The concomitant increase in DCX and PCNA immunoreactivity suggests that blockade of
abstinence-induced depression-like behavior by desipramine may have been mediated by
changes in multiple phases of hippocampal neurogenesis. Evidence indicates that NPCs
express PCNA during and up to 4 days after the S phase of the cell cycle (Mandyam et al,
2007); however, DCX expression peaks in the dentate gyrus between 1 and 21 days after the
S phase when NPC differentiation is occurring (Brown et al, 2003). Immunohistochemical
studies of PCNA and DCX performed on a single day, therefore, are likely labeling mostly
distinct populations of new cells. Thus, it is not clear from the present study if antidepressant
treatment specifically protected against the abstinence-induced reduction in NPC
proliferation or enhanced survival of post-proliferative cells born during the abstinence
phase, either or both of which would lead to an increase in new neurons. Alternatively, it is
also plausible that protection against the abstinence-induced reduction in the number of new
neurons by desipramine may have been conferred by a compensatory burst in NPC
proliferation, which has been reported to occur 7 days after withdrawal from binge injection
of alcohol (Nixon and Crews, 2004). These potential alternatives could be addressed in
future studies that further elucidate the time course of changes in various phases of
neurogenesis during abstinence from alcohol drinking. In either case, it appears from the
present study that chronic antidepressant treatment protects against abstinence-induced
reductions in both NPC proliferation and development of new neurons.
Although there is no single neurobiological mechanism that accounts for the behavioral
pathologies associated with alcoholism or depression, converging evidence suggests that
alcoholism and depression (and perhaps their co-occurrence) may share common molecular
mechanisms of action. For example, chronic alcohol exposure reduces cAMP response
element-binding protein (CREB) activity in the dentate gyrus (Bison and Crews, 2003).
Reductions in CREB activity and function can occur during acute and protracted alcohol
withdrawal and are associated with negative mood states, such as anxiety (reviewed by
(Pandey, 2003)). By contrast, a variety of antidepressant drugs increase levels of CREB
mRNA in the hippocampus (Nibuya et al, 1996). Viral overexpression of CREB in the
dentate gyrus of the hippocampus also results in less depression-like behavior in both the
FST and learned helplessness tests (Chen et al, 2001). Accordingly, alcohol withdrawal is
associated with reduced expression of CREB-target genes including brain-derived
neurotrophic factor (BDNF) in the dentate gyrus (Tapia-Arancibia et al, 2001) whereas
several different antidepressant drugs, including desipramine which was used in the present
study, increase BDNF mRNA in the hippocampus (Nibuya et al, 1995). Moreover, chronic
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alcohol reduces hippocampal neurogenesis (Nixon and Crews, 2002) but the behavioral
effects of antidepressant medications may require hippocampal neurogenesis(Santarelli et al,
2003). These and other findings have led to emerging theories that implicate a CREB–
BDNF–neurogenesis pathway in both the etiology of depression and antidepressant efficacy
(Duman et al, 2001; Malberg et al, 2000; Thomas and Peterson, 2003). Overall, CREB and
BDNF activity in the dentate gyrus appear to be important mediators of antidepressant
efficacy and raise the hypothesis that decreases in p-CREB, such as those that occur after
chronic alcohol, have the potential to induce behavioral despair and reductions in
neurogenesis as seen in the present study.
Several features of the present study merit further discussion. First, although the data
presented in this study suggest that depression-like behavior and related neuroadaptations
emerge during abstinence following chronic drinking, it is worth mentioning that no single
animal model of depression is sufficient to characterize the human condition of depression.
In these experiments, we sought to characterize changes in affective behavior at a single
time point during abstinence, which limited the number and type of behavioral measures we
were able to conduct. Thus, it will be important in future studies to utilize other validated
rodent behavioral tests of anxiety- and depression-like behavior to confirm and extend the
present results. Second, it is worth noting that a 300 mg/kg dose of BrdU was chosen to
examine NPC survival based on a published method (Cameron and McKay, 2001), which
suggested that this dose labels all cells in the S phase in the rat. However, a recent
publication (Mandyam et al, 2007) has demonstrated that 150 mg/kg is sufficient to label all
cells in the S phase in the mouse. Thus, we cannot rule out the possibility that our BrdU
injection regimen caused toxicity to dividing cells, especially in combination with
subsequent alcohol consumption; however, as no differences were found in the number of
BrdU-labeled cells between any groups, we feel this probably did not contribute
significantly to our results. Finally, our results showing that desipramine did not alter FST
performance in or neurogenesis in control mice are somewhat surprising. Another study
demonstrated that chronic desipramine treatment increases neurogenesis and decreases
depression-like behavior in control mice; however, that study used utilized twice-daily
administration of 12.5 mg/kg desipramine (Gur et al, 2007), indicating that a higher dose
may have produced changes in our control animals. Additionally, although acute
desipramine treatment has been shown to reduce immobility in the FST (Lucki et al, 2001),
we did not administer desipramine on the day of the test. Our results are similar to those
found by MacQueen et al (2003), showing that 14 days administration of desipramine at the
same dose used in the current study (15 mg/kg) and not administered on the day of testing
reduced immobility in the FST in mice in which depression had been induced, but not in
control mice.
In conclusion, alcoholism and depression are two devastating disorders that commonly co-
occur. Emerging evidence indicates that alcohol has detrimental effects on molecular
pathways that may be involved in the pathophysiology of depression. Important clinical
evidence indicates that depression that emerges during abstinence has a greater negative
impact on relapse rates than pre-existing depression. Preclinical studies on this topic are
lacking. To address this need, we have developed and validated a novel model of alcohol
drinking-induced depression-like behavior in mice. The data presented here lend further
support to the hypothesis that hippocampal neurogenesis is related to depression, as well as
antidepressant efficacy. We show that abstinence following chronic alcohol drinking leads
to a decrease in adult hippocampal neurogenesis at a time when depression-like behavior is
also evident. Antidepressant treatment during abstinence prevents both the decrease in new
neurons and the depression-like behavior, suggesting a mechanistic link. Given that new
neurons constitute 6% of the total granule cells in the hippocampus, neurogenesis is crucial
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for hippocampal function (Cameron and McKay, 2001) and of potential importance to the
etiology and treatment of alcoholism and comorbid depression.
Acknowledgments
This work was supported by Grants AA016629 and AA011605 to CWH, AA06069 to FTC, and AA016043 to JRS
from the National Institute on Alcohol Abuse and Alcoholism, and by the Bowles Center for Alcohol Studies.
REFERENCES
Aberg E, Hofstetter CP, Olson L, Brene S. Moderate ethanol consumption increases hippocampal cell
proliferation and neurogenesis in the adult mouse. Int J Neuropsychopharmacol 2005;8:557–567.
[PubMed: 16202182]
Baldwin HA, Rassnick S, Rivier J, Koob GF, Britton KT. CRF antagonist reverses the ‘anxiogenic’
response to ethanol withdrawal in the rat. Psychopharmacology (Berl) 1991;103:227–232.
[PubMed: 2027923]
Bison S, Crews F. Alcohol withdrawal increases neuropeptide Y immunoreactivity in rat brain.
Alcohol Clin Exp Res 2003;27:1173–1183. [PubMed: 12878925]
Brown JP, Couillard-Despres S, Cooper-Kuhn CM, Winkler J, Aigner L, Kuhn HG. Transient
expression of doublecortin during adult neurogenesis. J Comp Neurol 2003;467:1–10. [PubMed:
14574675]
Cameron HA, Gould E. Adult neurogenesis is regulated by adrenal steroids in the dentate gyrus.
Neuroscience 1994;61:203–209. [PubMed: 7969902]
Cameron HA, McKay RD. Adult neurogenesis produces a large pool of new granule cells in the
dentate gyrus. J Comp Neurol 2001;435:406–417. [PubMed: 11406822]
Carlezon WA Jr, Duman RS, Nestler EJ. The many faces of CREB. Trends Neurosci 2005;28:436–
445. [PubMed: 15982754]
Celis JE, Madsen P, Celis A, Nielsen HV, Gesser B. Cyclin (PCNA, auxiliary protein of DNA
polymerase delta) is a central component of the pathway(s) leading to DNA replication and cell
division. FEBS Lett 1987;220:1–7. [PubMed: 2886367]
Chen AC, Shirayama Y, Shin KH, Neve RL, Duman RS. Expression of the cAMP response element
binding protein (CREB) in hippocampus produces an antidepressant effect. Biol Psychiatry
2001;49:753–762. [PubMed: 11331083]
Costall B, Kelly ME, Naylor RJ. The anxiolytic and anxiogenic actions of ethanol in a mouse model. J
Pharm Pharmacol 1988;40:197–202. [PubMed: 2899150]
Couillard-Despres S, Winner B, Schaubeck S, Aigner R, Vroemen M, Weidner N, et al. Doublecortin
expression levels in adult brain reflect neurogenesis. Eur J Neurosci 2005;21:1–14. [PubMed:
15654838]
Crews FT, Nixon K. Alcohol, neural stem cells, and adult neurogenesis. Alcohol Res Health
2003;27:197–204. [PubMed: 15303631]
Crews FT, Nixon K, Wilkie ME. Exercise reverses ethanol inhibition of neural stem cell proliferation.
Alcohol 2004;33:63–71. [PubMed: 15353174]
Cryan JF, Valentino RJ, Lucki I. Assessing substrates underlying the behavioral effects of
antidepressants using the modified rat forced swimming test. Neurosci Biobehav Rev
2005;29:547–569. [PubMed: 15893822]
Dalvi A, Lucki I. Murine models of depression. Psychopharmacology (Berl) 1999;147:14–16.
[PubMed: 10591858]
Dranovsky A, Hen R. Hippocampal neurogenesis: regulation by stress and antidepressants. Biol
Psychiatry 2006;59:1136–1143. [PubMed: 16797263]
Duman RS, Malberg J, Nakagawa S. Regulation of adult neurogenesis by psychotropic drugs and
stress. J Pharmacol Exp Ther 2001;299:401–407. [PubMed: 11602648]
Duman RS, Malberg J, Nakagawa S, D'Sa C. Neuronal plasticity and survival in mood disorders. Biol
Psychiatry 2000;48:732–739. [PubMed: 11063970]
Stevenson et al. Page 14













Duman RS, Malberg J, Thome J. Neural plasticity to stress and antidepressant treatment. Biol
Psychiatry 1999;46:1181–1191. [PubMed: 10560024]
Gage FH. Neurogenesis in the adult brain. J Neurosci 2002;22:612–613. [PubMed: 11826087]
Garbutt JC, West SL, Carey TS, Lohr KN, Crews FT. Pharmacological treatment of alcohol
dependence: a review of the evidence. JAMA 1999;281:1318–1325. [PubMed: 10208148]
Grant BF. Comorbidity between DSM-IV drug use disorders and major depression: results of a
national survey of adults. J Subst Abuse 1995;7:481–497. [PubMed: 8838629]
Greenfield SF, Weiss RD, Muenz LR, Vagge LM, Kelly JF, Bello LR, et al. The effect of depression
on return to drinking: a prospective study. Arch Gen Psychiatry 1998;55:259–265. [PubMed:
9510220]
Gregus A, Wintink AJ, Davis AC, Kalynchuk LE. Effect of repeated corticosterone injections and
restraint stress on anxiety and depression-like behavior in male rats. Behav Brain Res
2005;156:105–114. [PubMed: 15474655]
Gur TL, Conti AC, Holden J, Bechtholt AJ, Hill TE, Lucki I, et al. cAMP response element-binding
protein deficiency allows for increased neurogenesis and a rapid onset of antidepressant response.
J Neurosci 2007;27:7860–7868. [PubMed: 17634380]
Hasin D, Liu X, Nunes E, McCloud S, Samet S, Endicott J. Effects of major depression on remission
and relapse of substance dependence. Arch Gen Psychiatry 2002;59:375–380. [PubMed:
11926938]
He J, Nixon K, Shetty AK, Crews FT. Chronic alcohol exposure reduces hippocampal neurogenesis
and dendritic growth of newborn neurons. Eur J Neurosci 2005;21:2711–2720. [PubMed:
15926919]
Hebb, DO. The Organization of Behavior. Wiley; New York: 1949.
Henn FA, Vollmayr B. Neurogenesis and depression: etiology or epiphenomenon? Biol Psychiatry
2004;56:146–150. [PubMed: 15271582]
Herrera DG, Yague AG, Johnsen-Soriano S, Bosch-Morell F, Collado-Morente L, Muriach M, et al.
Selective impairment of hippocampal neurogenesis by chronic alcoholism: protective effects of an
antioxidant. Proc Natl Acad Sci USA 2003;100:7919–7924. [PubMed: 12792022]
Hodge CW, Mehmert KK, Kelley SP, McMahon T, Haywood A, Olive MF, et al. Supersensitivity to
allosteric GABA(A) receptor modulators and alcohol in mice lacking PKCepsilon. Nat Neurosci
1999;2:997–1002. [PubMed: 10526339]
Hodge CW, Raber J, McMahon T, Walter H, Sanchez-Perez AM, Olive MF, et al. Decreased anxiety-
like behavior, reduced stress hormones, and neurosteroid supersensitivity in mice lacking protein
kinase Cepsilon. J Clin Invest 2002;110:1003–1010. [comment]. [PubMed: 12370278]
Hwang BH, Kunkler PE, Tarricone BJ, Hingtgen JN, Nurnberger JI Jr. Stress-induced changes of
norepinephrine uptake sites in the locus coeruleus of C57BL/6J and DBA/2J mice: a quantitative
autoradiographic study using [3H]-tomoxetine. Neurosci Lett 1999;265:151–154. [PubMed:
10327153]
Jacobs BL, Praag H, Gage FH. Adult brain neurogenesis and psychiatry: a novel theory of depression.
Mol Psychiatry 2000;5:262–269. [PubMed: 10889528]
Johnson SA, Fournier NM, Kalynchuk LE. Effect of different doses of corticosterone on depression-
like behavior and HPA axis responses to a novel stressor. Behav Brain Res 2006;168:280–288.
[PubMed: 16386319]
Joshi D, Naidu PS, Singh A, Kulkarni SK. Protective effect of quercetin on alcohol abstinence-induced
anxiety and convulsions. J Med Food 2005;8:392–396. [PubMed: 16176153]
Kempermann G. Why new neurons? Possible functions for adult hippocampal neurogenesis. J
Neurosci 2002;22:635–638. [PubMed: 11826092]
Kessler RC, Crum RM, Warner LA, Nelson CB, Schulenberg J, Anthony JC. Lifetime co-occurrence
of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the National
Comorbidity Survey. Arch Gen Psychiatry 1997;54:313–321. [PubMed: 9107147]
Kliethermes CL. Anxiety-like behaviors following chronic ethanol exposure. Neurosci Biobehav Rev
2005;28:837–850. [PubMed: 15642625]
Stevenson et al. Page 15













Kliethermes CL, Cronise K, Crabbe JC. Anxiety-like behavior in mice in two apparatuses during
withdrawal from chronic ethanol vapor inhalation. Alcohol Clin Exp Res 2004;28:1012–1019.
[PubMed: 15252287]
Krude T. Chromatin replication: finding the right connection. Curr Biol 1999;9:R394–R396. [PubMed:
10359691]
Le Fauve CE, Litten RZ, Randall CL, Moak DH, Salloum IM, Green AI. Pharmacological treatment of
alcohol abuse/dependence with psychiatric comorbidity. Alcohol Clin Exp Res 2004;28:302–312.
[PubMed: 15112938]
Lucki I, Dalvi A, Mayorga AJ. Sensitivity to the effects of pharmacologically selective antidepressants
in different strains of mice. Psychopharmacology (Berl) 2001;155:315–322. [PubMed: 11432695]
Lynskey MT. The comorbidity of alcohol dependence and affective disorders: treatment implications.
Drug Alcohol Depend 1998;52:201–209. [PubMed: 9839146]
MacQueen GM, Ramakrishnan K, Ratnasingan R, Chen B, Young LT. Desipramine treatment reduces
the long-term behavioural and neurochemical sequelae of early-life maternal separation. Int J
Neuropsychopharmacol 2003;6:391–396. [PubMed: 14641986]
Malberg JE, Blendy JA. Antidepressant action: to the nucleus and beyond. Trends Pharmacol Sci
2005;26:631–638. [PubMed: 16246434]
Malberg JE, Duman RS. Cell proliferation in adult hippocampus is decreased by inescapable stress:
reversal by fluoxetine treatment. Neuropsychopharmacology 2003;28:1562–1571. [PubMed:
12838272]
Malberg JE, Eisch AJ, Nestler EJ, Duman RS. Chronic antidepressant treatment increases
neurogenesis in adult rat hippocampus. J Neurosci 2000;20:9104–9110. [PubMed: 11124987]
Mandyam CD, Harburg GC, Eisch AJ. Determination of key aspects of precursor cell proliferation,
cell cycle length and kinetics in the adult mouse subgranular zone. Neuroscience 2007;146:108–
122. [PubMed: 17307295]
Miller HL, Delgado PL, Salomon RM, Berman R, Krystal JH, Heninger GR, et al. Clinical and
biochemical effects of catecholamine depletion on antidepressant-induced remission of depression.
Arch Gen Psychiatry 1996;53:117–128. [PubMed: 8629887]
Ming GL, Song H. Adult neurogenesis in the mammalian central nervous system. Annu Rev Neurosci
2005;28:223–250. [PubMed: 16022595]
Mirescu C, Gould E. Stress and adult neurogenesis. Hippocampus 2006;16:233–238. [PubMed:
16411244]
Moy SS, Knapp DJ, Criswell HE, Breese GR. Flumazenil blockade of anxiety following ethanol
withdrawal in rats. Psychopharmacology (Berl) 1997;131:354–360. [PubMed: 9226737]
Mueller TI, Lavori PW, Keller MB, Swartz A, Warshaw M, Hasin D, et al. Prognostic effect of the
variable course of alcoholism on the 10-year course of depression. Am J Psychiatry
1994;151:701–706. [PubMed: 8166311]
Nibuya M, Morinobu S, Duman RS. Regulation of BDNF and trkB mRNA in rat brain by chronic
electroconvulsive seizure and antidepressant drug treatments. J Neurosci 1995;15:7539–7547.
[PubMed: 7472505]
Nibuya M, Nestler EJ, Duman RS. Chronic antidepressant administration increases the expression of
cAMP response element binding protein (CREB) in rat hippocampus. J Neurosci 1996;16:2365–
2372. [PubMed: 8601816]
Nixon K. Alcohol and adult neurogenesis: Roles in neurodegeneration and recovery in chronic
alcoholism. Hippocampus 2006;16:287–295. [PubMed: 16421863]
Nixon K, Crews FT. Binge ethanol exposure decreases neurogenesis in adult rat hippocampus. J
Neurochem 2002;83:1087–1093. [PubMed: 12437579]
Nixon K, Crews FT. Temporally specific burst in cell proliferation increases hippocampal
neurogenesis in protracted abstinence from alcohol. J Neurosci 2004;24:9714–9722. [PubMed:
15509760]
Ostacher MJ. Comorbid alcohol and substance abuse dependence in depression: impact on the
outcome of antidepressant treatment. Psychiatr Clin North Am 2007;30:69–76. [PubMed:
17362804]
Stevenson et al. Page 16













Pandey SC. Anxiety and alcohol abuse disorders: a common role for CREB and its target, the
neuropeptide Y gene. Trends Pharmacol Sci 2003;24:456–460. [PubMed: 12967770]
Pandey SC, Zhang D, Mittal N, Nayyar D. Potential role of the gene transcription factor cyclic AMP-
responsive element binding protein in ethanol withdrawal-related anxiety. J Pharmacol Exp Ther
1999;288:866–878. [PubMed: 9918601]
Paxinos, G.; Franklin, KBJ. The Mouse Brain in Sterotaxic Coordinates. 2nd edn. Academic Press;
New York: 2001.
Pettinati HM. Antidepressant treatment of co-occurring depression and alcohol dependence. Biol
Psychiatry 2004;56:785–792. [PubMed: 15556124]
Plaznik A, Tamborska E, Hauptmann M, Bidzinski A, Kostowski W. Brain neurotransmitter systems
mediating behavioral deficits produced by inescapable shock treatment in rats. Brain Res
1988;447:122–132. [PubMed: 2898272]
Pohorecky LA. Withdrawal from ethanol: simple quantitative behavioral tests for its evaluation.
Psychopharmacology (Berl) 1976;50:125–129. [PubMed: 826951]
Popken GJ, Farel PB. Sensory neuron number in neonatal and adult rats estimated by means of
stereologic and profile-based methods. J Comp Neurol 1997;386:8–15. [PubMed: 9303521]
Porsolt RD, Bertin A, Jalfre M. Behavioral despair in mice: a primary screening test for
antidepressants. Archives Internationales de Pharmacodynamie et de Therapie 1977;229:327–336.
[PubMed: 596982]
Prediger RD, da Silva GE, Batista LC, Bittencourt AL, Takahashi RN. Activation of adenosine A1
receptors reduces anxiety-like behavior during acute ethanol withdrawal (hangover) in mice.
Neuropsychopharmacology 2006;31:2210–2220. [PubMed: 16407902]
Prince CR, Anisman H. Acute and chronic stress effects on performance in a forced-swim task. Behav
Neural Biol 1984;42:99–119. [PubMed: 6543117]
Rao MS, Shetty AK. Efficacy of doublecortin as a marker to analyse the absolute number and dendritic
growth of newly generated neurons in the adult dentate gyrus. Eur J Neurosci 2004;19:234–246.
[PubMed: 14725617]
Rasmussen DD, Mitton DR, Green J, Puchalski S. Chronic daily ethanol and withdrawal: behavioral
changes during prolonged abstinence. Alcohol Clin Exp Res 2001;25:999–1005. [PubMed:
11505024]
Rassnick S, Heinrichs SC, Britton KT, Koob GF. Micro-injection of a corticotropin-releasing factor
antagonist into the central nucleus of the amygdala reverses anxiogenic-like effects of ethanol
withdrawal. Brain Res 1993;605:25–32. [PubMed: 8467387]
Santarelli L, Saxe M, Gross C, Surget A, Battaglia F, Dulawa S, et al. Requirement of hippocampal
neurogenesis for the behavioral effects of antidepressants. Science 2003;301:805–809. [PubMed:
12907793]
Schuckit MA, Tipp JE, Bergman M, Reich W, Hesselbrock VM, Smith TL. Comparison of induced
and independent major depressive disorders in 2,945 alcoholics. Am J Psychiatry 1997;154:948–
957. [PubMed: 9210745]
Snyder JS, Kee N, Wojtowicz JM. Effects of adult neurogenesis on synaptic plasticity in the rat
dentate gyrus. J Neurophysiol 2001;85:2423–2431. [PubMed: 11387388]
Sparta DR, Fee JR, Knapp DJ, Breese GR, Thiele TE. Elevated anxiety-like behavior following
ethanol exposure in mutant mice lacking neuropeptide Y (NPY). Drug Alcohol Depend
2007;90:297–300. [PubMed: 17482381]
Tanapat P, Hastings NB, Rydel TA, Galea LA, Gould E. Exposure to fox odor inhibits cell
proliferation in the hippocampus of adult rats via an adrenal hormone-dependent mechanism. J
Comp Neurol 2001;437:496–504. [PubMed: 11503148]
Tapia-Arancibia L, Rage F, Givalois L, Dingeon P, Arancibia S, Beauge F. Effects of alcohol on brain-
derived neurotrophic factor mRNA expression in discrete regions of the rat hippocampus and
hypothalamus. J Neurosci Res 2001;63:200–208. [PubMed: 11169630]
Thomas RM, Peterson DA. A neurogenic theory of depression gains momentum. Mol Interv
2003;3:441–444. [PubMed: 14993452]
Stevenson et al. Page 17













Thome J, Sakai N, Shin K, Steffen C, Zhang YJ, Impey S, et al. cAMP response element-mediated
gene transcription is upregulated by chronic antidepressant treatment. J Neurosci 2000;20:4030–
4036. [PubMed: 10818138]
Warner-Schmidt JL, Duman RS. Hippocampal neurogenesis: opposing effects of stress and
antidepressant treatment. Hippocampus 2006;16:239–249. [PubMed: 16425236]
Yew DT, Sha O, Li WW, Lam TT, Lorke DE. Proliferation and apoptosis in the epithelium of the
developing human cornea and conjunctiva. Life Sci 2001;68:2987–3003. [PubMed: 11411798]
Zhao Y, Weiss F, Zorrilla EP. Remission and resurgence of anxiety-like behavior across protracted
withdrawal stages in ethanol-dependent rats. Alcohol Clin Exp Res 2007;31:1505–1515. [PubMed:
17760785]
Stevenson et al. Page 18














Timeline of experimental procedure. Each stage of the experiment is labeled as a separate
section in the arrow. The duration of each stage (number of days) is shown under the arrow.
(a) After 7 days of adaptation to the lab, mice received daily injections of BrdU (300 mg/kg,
i.p.) for 3 days. The following day, the two-bottle drinking procedure began. Mice
voluntarily self-administered alcohol vs water in the home cage for 28 days. On the 28th
day, alcohol bottles were removed from the cage. One day later or 14 days later, locomotor
activity and forced swim tests were performed. The following day, mice were killed, and
brains were removed. (b) After 7 days of adaptation to the lab, mice began 28 days of a two-
bottle drinking procedure. On the 28th day, alcohol bottles were removed and mice received
their first injection of either vehicle or desipramine (15 mg/kg, i.p.). Injections were given
once daily for 14 days. One day after the last injection, locomotor activity and forced swim
tests were performed. One day later, mice were killed, and brains were removed.
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Abstinence from alcohol drinking increases depression-like behavior. Mean immobility
(sec) in the forced swim test (FST) increased as a function of days of abstinence from
alcohol drinking as compared with water-drinking controls. Data are plotted as mean ± SEM
from n = 12 mice in each condition. Please note that the y axis origin is 50 s. *Significantly
different from water-drinking control, p<0.05 (Dunnett's t-test).
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No changes in survival of NPCs. (a). The mean number of BrdU-labeled cells that survive is
unchanged in the dentate gyrus following voluntary drinking and 1- or 14-day abstinence.
(b) Representative images showing BrdU-labeled cells in the dentate gyrus from control, 1
day of abstinence, and 14 days of abstinence. (c) Triple-label immunofluorescence was used
to evaluate differentiation of surviving NPCs. A representative dentate gyrus is shown.
GFAP-labeled glial cells are shown in blue, NeuN-labeled neuronal nuclei are shown in red,
BrdU-labeled cells are shown in green. (d) An orthogonal view of a representative cell
showing colocalization of BrdU and NeuN. The number of surviving BrdU-labeled cells that
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colabeled with the neuronal marker NeuN was unchanged in ethanol-treated brains. Data are
plotted as mean ± SEM from n = 9–12 mice in each condition.
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Abstinence from alcohol reduces adult hippocampal neurogenesis. PCNA and DCX
immunohistochemistry. (a) Relative change in PCNA immunoreactivity (IR) in the dentate
gyrus showing a reduction in NPC proliferation as a function of 0, 1, or 14 days of
abstinence from alcohol drinking. (b) Relative decrease in DCX IR showing that the number
of new neurons in the dentate gyrus is reduced as a function of abstinence from alcohol
drinking. (c and d) Representative images of dentate gyrus from control, 0 days, 2 days, and
14 days of abstinence for PCNA IR (c) and DCX IR (d). Arrow heads point to representative
PCNA-labeled cells. Mean data were obtained from averaging results from four tissue
sections per mouse and plotted as percent change from water-drinking control.
*Significantly different from water-drinking control, p<0.05 (Dunnett's t-test).
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Desipramine treatment prevents abstinence-induced changes in depression-like behavior and
neurogenesis. (a) Abstinence-induced increase in immobility (sec) in the forced swim test
(FST) was completely blocked by treatment with desipramine during 14 days of abstinence
(n = 12 per group). Please note that the y axis origin is 50 s. *Significantly different from
water-drinking mice that received vehicle (desipramine, 0 mg/kg), p = 0.007, and
significantly different from ethanol- 15 mg/kg, p = 0.008 (Tukey test). (b) Desipramine
treatment (14 days) prevented the abstinence-induced decrease in PCNA immunoreactivity
in the dentate gyrus (n = 12 per group). *Significantly different from water-drinking mice
that received vehicle (desipramine, 0 mg/kg), p = 0.012, (Tukey test). (c) Abstinence-
induced reduction in DCX density was completely blocked by desipramine during 14 days
of abstinence (n = 12 per group). *Significantly different from water-drinking mice that
received vehicle (desipramine, 0 mg/kg), p = 0.004, and significantly different from ethanol-
15 mg/kg, p = 0.005 (Tukey test). Mean ± SEM data for PCNA and DCX IR were obtained
by averaging results from four tissue sections per mouse and plotted as percent change from
water- 0 mg/kg controls. (d and e) Representative images of dentate gyrus of PCNA IR (d)
and DCX IR (e) from water and alcohol exposed mice that received Desipramine (0 or 15
mg/kg) during the 14-day abstinence period. Arrow heads point to representative PCNA-
labeled cells.
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Table 1
Anxiety-like Behavior and Locomotor Activity Associated with Abstinence following Voluntary Alcohol
Drinking
Abstinence (days) Time in center (sec) Distance traveled (cm)
Control 190.2 ± 17.6 4668.9 ± 245.6
1 90.75 ± 10.2* 5402.8 ± 242.9
14 147.9 ± 12.1 4503.5 ± 204.7
Anxiety-like behavior (time in center) and locomotor activity (distance traveled).
*
Significantly different from control, p<0.05, Dunnett's test.
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